Form 4: Colgate-Palmolive CEO Noel Wallace Sells 33,333 Shares Under 10b5-1 Plan
SEC Form 4 Filing
Colgate-Palmolive's CEO, Noel Wallace, sold 33,333 shares of common stock at $95 per share on November 22, 2024, as part of a pre-arranged trading plan.
Summary
- Noel Wallace, the Chairman, President, and CEO of Colgate-Palmolive, sold 33,333 shares of the company's common stock on November 22, 2024.
- The sale was executed at a price of $95 per share.
- This transaction was conducted under a Rule 10b5-1 trading plan adopted by Mr. Wallace on August 21, 2024.
- Following the transaction, Mr. Wallace directly owns 270,689 shares of Colgate-Palmolive common stock.
- He also indirectly owns 52,561 shares through the Issuer's 401(k) Plan Trustee, 52,000 shares through a Spouse Trust, and 335 shares through another Trust.
Sentiment
Score: 5
Explanation: The document describes a routine stock sale under a pre-arranged plan, which is neither positive nor negative for the company's outlook.
Risks
- While the sale was part of a pre-arranged plan, large sales by executives can sometimes be perceived negatively by the market.
Management Comments
- The transaction was part of Mr. Wallace's long-term asset diversification, tax, and financial planning strategy.
Industry Context
Executive stock sales are a common occurrence, especially when part of pre-arranged trading plans. This transaction is not unusual for a CEO of a large public company.
Comparison to Industry Standards
- Rule 10b5-1 trading plans are a standard practice for executives at publicly traded companies to avoid accusations of insider trading.
- The volume of shares sold is not unusual for a CEO's portfolio diversification strategy.
- Other CEOs in similar large consumer goods companies also use 10b5-1 plans for stock transactions.
Stakeholder Impact
- The sale may have a minor impact on shareholder sentiment, but it is unlikely to significantly affect the company's operations or financial health.
Key Dates
| Date | Description |
|---|---|
| 08/21/2024 | Date Noel Wallace adopted the Rule 10b5-1 trading plan. |
| 11/22/2024 | Date of the stock sale transaction. |
| 11/26/2024 | Date the Form 4 was signed. |
Keywords
Colgate-Palmolive, CEO, Noel Wallace, stock sale, Rule 10b5-1, insider trading, equity securities, share transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.